PCIG vs. GNOM ETF Comparison
Comparison of Polen Capital International Growth ETF (PCIG) to Global X Genomics & Biotechnology ETF (GNOM)
PCIG
Polen Capital International Growth ETF
PCIG Description
PCIG aims to deliver sustainable, above-average earnings growth and long-term stock price appreciation within the global ex-US equity market. The strategy is rooted in fundamental research, selecting 25-35 large-cap growth companies with a sustainable edge like consistent earnings growth, robust balance sheets, and shareholder-oriented management teams. Such companies are selected within industries characterized by high barriers to entry, such as those requiring substantial capital investment, government approvals, or significant intellectual property. Moreover, it integrates ESG factors into the investment process. While the fund may concentrate investments in the consumer discretionary and financial sectors, it avoids over-concentration in any one industry. Investments are typically held for the long term but are subject to period review and potential sale based on changing market conditions, company performance, or perceived threats to competitive advantage.
Grade (RS Rating)
Last Trade
$9.46
Average Daily Volume
5,619
10
GNOM
Global X Genomics & Biotechnology ETF
GNOM Description
The investment seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics Index ("underlying index"). The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.Grade (RS Rating)
Last Trade
$9.83
Average Daily Volume
43,119
40
Performance
| Period | PCIG | GNOM |
|---|---|---|
| 30 Days | -2.52% | -8.90% |
| 60 Days | -4.25% | -13.16% |
| 90 Days | -4.83% | -14.89% |
| 12 Months | -5.98% |
0 Overlapping Holdings
| Symbol | Grade | Weight in PCIG | Weight in GNOM | Overlap |
|---|
PCIG Underweight 40 Positions Relative to GNOM
| Symbol | Grade | Weight | |
|---|---|---|---|
| VCYT | B | -4.69% | |
| CRSP | D | -4.66% | |
| NTRA | A | -4.41% | |
| ARWR | D | -4.31% | |
| TECH | F | -4.21% | |
| ILMN | C | -4.14% | |
| QGEN | D | -4.09% | |
| RNA | C | -4.06% | |
| BEAM | D | -4.03% | |
| A | D | -3.93% | |
| BNTX | C | -3.83% | |
| BMRN | F | -3.71% | |
| ALNY | D | -3.71% | |
| RARE | F | -3.63% | |
| LEGN | D | -3.56% | |
| SRPT | F | -3.55% | |
| NTLA | F | -3.23% | |
| MRNA | F | -3.13% | |
| TXG | F | -2.93% | |
| MYGN | F | -2.8% | |
| RCKT | F | -2.62% | |
| GILD | C | -2.17% | |
| CDNA | D | -2.13% | |
| VRTX | D | -2.09% | |
| VIR | D | -1.61% | |
| MRVI | F | -1.26% | |
| PACB | F | -1.18% | |
| SGMO | C | -0.99% | |
| RGNX | D | -0.95% | |
| ALLO | F | -0.79% | |
| VERV | F | -0.74% | |
| FLGT | F | -0.73% | |
| SANA | F | -0.65% | |
| QURE | D | -0.64% | |
| EDIT | F | -0.5% | |
| PSTX | D | -0.44% | |
| CRBU | D | -0.42% | |
| TSVT | F | -0.41% | |
| LYEL | F | -0.31% | |
| SCLX | F | -0.01% |
PCIG: Top Represented Industries & Keywords
GNOM: Top Represented Industries & Keywords
Compare ETFs
